Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs
Journal
Life Sciences
ISSN
0024-3205
Date Issued
2023
Author(s)
Ivonne Olmedo
Daniela Martínez
Javiera Carrasco-Rojas
José A. Jara
Type
Resource Types::text::journal::journal article
Cite this document
Olmedo, I., Martínez, D., Carrasco-Rojas, J., & Jara, J. A. (2023). Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs. Life Sciences, 331, 122065. https://doi.org/10.1016/j.lfs.2023.122065
Subjects
cancer stem cells
;
drugs target
;
mitochondria metabolism
;
oral cancer
;
carcinoma, squamous cell
;
head and neck neoplasms
;
humans
;
mitochondria
;
mouth neoplasms
;
neoplastic stem cells
;
squamous cell carcinoma of head and neck
;
aldehyde dehydrogenase isoenzyme 1
;
atorvastatin
;
bmi1 protein
;
carboplatin
;
cd133 antigen
;
cd147 antigen
;
cd24 antigen
;
cell marker
;
cisplatin
;
common acute lymphoblastic leukemia antigen
;
cyclophosphamide
;
docetaxel
;
doxorubicin
;
epirubicin
;
everolimus
;
fluorouracil
;
hermes antigen
;
isoliquiritigenin
;
lapatinib
;
letrozole
;
leucine rich repeat containing g protein coupled receptor 5
;
metformin
;
musashi 1
;
octamer transcription factor 4
;
phenformin
;
salinomycin
;
scatter factor receptor
;
stat3 protein
;
stem cell factor receptor
;
transcription factor nanog
;
transcription factor sox2
;
trastuzumab
;
unclassified drug
;
zoledronic acid
;
aerobic glycolysis
;
autophagy (cellular)
;
cancer prognosis
;
cancer recurrence
;
cancer stem cell
;
cell invasion
;
citric acid cycle
;
fatty acid oxidation
;
human
;
metastasis
;
mitochondrion
;
mouth squamous cell carcinoma
;
oxidative phosphorylation
;
respiratory chain
;
review
;
warburg effect
;
cancer stem cell
;
head and neck squamous cell carcinoma
;
head and neck tumor
;
mitochondrion
;
mouth tumor
;
squamous cell carcinoma